SUBSCRIBE
SUBSCRIBE
News   Drug Development

CombinatoRx, Incorporated’s Diabetes Drug Meets Trial Goal, Shares Up

May 27, 2009 | 
1 min read

Bookmark and Share

CAMBRIDGE, Mass.-- CombinatoRx, Incorporated today reported positive results for its Phase 2 clinical study of CRx-401 as an add-on to metformin therapy in Type 2 diabetes.

Clinical research Phase II
MORE ON THIS TOPIC
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
March 13, 2025
 · 
1 min read
 · 
Lori Ellis
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Autoimmune disease
Amgen’s Uplizna Deepens Response Against Myasthenia Gravis at 1 Year
March 13, 2025
 · 
1 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Entrance to Pfizer's office in Belgium
Breast cancer
Pfizer, Arvinas Post Mixed Late-Stage Breast Cancer Data for Closely Watched PROTAC Drug
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac